Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketoconazole cream versus Nizoral cream versus placebo for interdigital tinea pedis
2006-006513-33Phase 3Terminated
- Sponsor
- Janssen Pharmaceutical
- Start
- Mar 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ketoconazole and Placebo-COD Research Private Ltd in interdigital tinea pedis (TP) (3 arms), sponsored by Janssen Pharmaceutical. Primary endpoints: Mycological cure at week 6 and Non-inferiority of ketoconazole 2% cream versus Nizoral cream. Started Mar 2007; status: terminated.
02
Drugs
ketoconazolePlacebo-COD Research Private Ltd
03
Conditions
interdigital tinea pedis (TP)
Beyond the preview
Go deeper on 2006-006513-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006513-33.